TY  - JOUR
TI  - LncRNAs in hepatocellular carcinoma: molecular drivers and emerging therapeutic targets
AU  - Sulaiman, Muhammad
AU  - Nie, Yimin
AU  - Chen, Ziyi
AU  - Hani, Umm E
AU  - Raza, Faisal
AU  - Yahya, Mussa Mussa
AU  - Zhang, Zhibo
AU  - Sher, Mujahid
AU  - Yang, Mei
AU  - Yuan, Shengtao
AU  - Sun, Chunyu
PY  - 2026
JO  - Exploration of Digestive Diseases
VL  - 5
SP  - 1005120
DO  - 10.37349/edd.2026.1005120
UR  - https://www.explorationpub.com/Journals/edd/Article/1005120
AB  - Hepatocellular carcinoma (HCC) functions as a major cancer-related death factor around the world. Research indicates that long non-coding RNAs (lncRNAs) play essential roles during HCC onset and development because they belong to the novel RNA subclass that extends beyond 200 nucleotides without protein-coding capability. LncRNAs regulate the expression of downstream target genes and cancer-related signaling pathways, thereby promoting the proliferation, migration, invasion, autophagy, and apoptosis of tumor cells. The study of lncRNA function has been substantially facilitated by the emergence of lncRNA-specific microarrays and the increased accessibility of next-generation sequencing technologies. The function of lncRNAs can be predicted using computational and molecular methodologies. LncRNAs have the potential to function as repressors, scaffolds, regulators of super-enhancers, or molecular decoys. Proliferation, invasion, survival, DNA damage response (DDR), and chromatin dynamics can all be influenced by lncRNAs. Additionally, they can affect stemness/differentiation. The recurrence of tumors may be facilitated by the aberrant expression of these transcripts, which may result in therapy resistance. LncRNAs have the potential to function as innovative prognostic or theranostic biomarkers in HCC and other malignancies. In addition, RNA-based therapeutics may be implemented to target lncRNAs as a novel treatment approach for primary or recurrent HCC. In this review, we investigate the functions of lncRNAs in the pathophysiology of HCC and suggest their potential for novel therapeutic application in the treatment of HCC.
ER  -